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Abstract
Background: Sodalis glossinidius, a gram-negative bacterial endosymbiont of the tsetse fly, has been proposed as a
potential in vivo drug delivery vehicle to control trypanosome parasite development in the fly, an approach known
as paratransgenesis. Despite this interest of S. glossinidius as a paratransgenic platform organism in tsetse flies, few
potential effector molecules have been identified so far and to date none of these molecules have been
successfully expressed in this bacterium.
Results: In this study, S. glossinidius was transformed to express a single domain antibody, (Nanobody®) Nb_An33,
that efficiently targets conserved cryptic epitopes of the variant surface glycoprotein (VSG) of the parasite
Trypanosoma brucei. Next, we analyzed the capability of two predicted secretion signals to direct the extracellular
delivery of significant levels of active Nb_An33. We show that the pelB leader peptide was successful in directing
the export of fully functional Nb_An33 to the periplasm of S. glossinidius resulting in significant levels of
extracellular release. Finally, S. glossinidius expressing pelBNb_An33 exhibited no significant reduction in terms of
fitness, determined by in vitro growth kinetics, compared to the wild-type strain.
Conclusions: These data are the first demonstration of the expression and extracellular release of functional
trypanosome-interfering Nanobodies® in S. glossinidius. Furthermore, Sodalis strains that efficiently released the
effector protein were not affected in their growth, suggesting that they may be competitive with endogenous
microbiota in the midgut environment of the tsetse fly. Collectively, these data reinforce the notion for the
potential of S. glossinidius to be developed into a paratransgenic platform organism.
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Background
Tsetse flies (Glossina sp.) are medically important, vivi-
parous dipterans that transmit Trypanosoma spp. para-
sites responsible for human sleeping sickness and
Animal African trypanosomiasis. This biological trans-
mission is based on a complex developmental cycle that
these protozoan parasites have to go through in the
tsetse fly alimentary tract and mouthparts (Trypanosoma
congolense) or salivary glands (T. brucei sp.). Similar to
other blood feeding insects, tsetse flies rely on bacterial
symbionts to acquire nutrients that are insufficiently
present in their diet and which they are unable to
synthesize themselves. Sodalis glossinidius is a mater-
nally inherited gram-negative bacterial endosymbiont of
the tsetse fly that can be found both inter- and intracel-
lularly in the tsetse fly midgut, muscle, fat body, milk
glands, and salivary glands [1]. Given the close proxi-
mity of S. glossinidius to the different insect tissues
where trypanosome parasites reside and the fact that it
is one of the few insect symbiotic bacteria that can be
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cultured and genetically modified in vitro [1-3], S. glossi-
nidius is considered as a potential in vivo drug delivery
vehicle to control T. congolense and T. brucei develop-
ment in the fly. This strategy involving the use of bac-
terial symbionts to express foreign proteins, designed to
block pathogen transmission, is often referred to as
paratransgenesis [4] and has been developed and pro-
posed to combat different insect-borne animal and
human diseases [5-7]. The control of the trypanosome
parasite in the tsetse fly using paratransgenic technology
requires the identification and characterization of gene
products that interfere with trypanosome development
without reducing the fitness of the tsetse host or its
symbiont.
To date, genes involved in insect immunity have
attracted most attention as potential antitrypanocidal
effectors. In Glossina morsitans morsitans, the host
defense genes attacin and defensin are up-regulated in
response to trypanosome infection [8-10] and antitrypa-
nosomal activity has been shown for the recombinant
attacin protein [11]. Another potential effector protein is
an antimicrobial host defense protein produced by
bovine neutrophils with trypanocidal activity, BMAP-27
[12]. Indeed, this bovine myeloid antimicrobial peptide
has been shown to exhibit high toxicity towards two
major life cycle stages of African trypanosomes (blood-
stream-form and procyclic-form) However, to date none
of these peptides have been successfully expressed in
the tsetse fly bacterial symbiont S. glossinidius.
The identification of monoclonal antibodies (mAbs)
that recognize parasite surface proteins, and their subse-
quent expression as single chain antibody gene frag-
ments (ScFv), provides an alternative as potential
antipathogenic effectors. The feasibility of expressing
ScFvs in bacterial symbionts that retain their functional
activities has been demonstrated in Rhodococcus [13]
and Pantoea agglomerans [7]. However, due to their
bulky size (30 kDa range) and complex architecture
mAbs are often prone to aggregation and reduced affi-
nity [14,15].
Nanobodies® (Nbs) represent the smallest known
intact antigen-binding fragments derived from heavy-
chain only antibodies (HCAbs), devoid of light chains,
naturally occurring in Camelidae and sharks [16-18]
(reviewed by [19]). Due to their ability to target unique
epitopes that are less well targeted by conventional anti-
bodies, Nbs are currently of high research interest for
various pharmaceutical applications, including diagnosis
and drug delivery [20,21]. Because of their superior
intrinsic properties, e.g. small size (13-15 kDa), strict
monomeric behavior and high in vitro stability [17,22]
Nbs are efficiently produced in micro-organisms such as
Escherichia coli [23] and therefore show high potential
as effector molecules in the paratransgenesis approach.
Nbs directed towards distinct regions of the variant-spe-
cific surface glycoprotein (VSG), abundantly present on
the surface of bloodstream trypanosomes, have already
been identified, targeting VSG epitopes that are inacces-
sible on live trypanosomes for larger antibodies [24]. An
essential aspect for a successful symbiont-based para-
transgenesis approach is the active release of the effector
molecules to the inner insect environment for efficient
targeting of the pathogen. However, few studies have
focused on the export of heterologous proteins to the
periplasmatic and/or outer environment of S.
glossinidius.
In this study, we aimed to investigate the potential of
S. glossinidius to express functional Nbs without inter-
fering with cell viability. Secondly, we evaluated the cap-
ability of two independent secretion signals, predicted to
be involved in different protein secretion pathways, to
deliver the effector proteins to the extracellular environ-
ment. We show that Nb_An33, recognizing a VSG epi-
tope on Trypanosoma brucei [24] was expressed by S.
glossinidius. Furthermore, we demonstrated that the
pectate lyaseB (pelB) signal peptide from Erwinia caroto-
vora is able to direct the export of fully functional
Nb_An33 to the periplasm of S. glossinidius resulting in
significant levels of extracellular release. Importantly,
Sodalis strains that efficiently released the effector pro-
tein were not affected in their growth, suggesting that
they may be competitive with endogenous microbiota in
the midgut environment of the tsetse fly.
Results
Expression of Nb_An33
We examined the capability of Sodalis glossinidius to
express/export Nb_An33 through the use of expression
plasmids harboring the coding sequence for Nb_An33
fused to two independent secretion signals, one of
which is native to S. glossinidius. A schematic presenta-
tion of the structure of the fused genes is shown in Fig-
ure 1. For the first secretion construct, Nb_An33 was
fused to the pelB leader sequence. As S. glossinidius is
devoid of a lac repressor, the presence of the lac pro-
moter resulted in a constitutive expression of pelBN-
b_An33. The second secretion signal was that for the
flagellin protein FliC of S. glossinidius, one of the most
abundant proteins on the bacterial surface and the
major component of the flagellum [25]. Here, the con-
struct contained the promoter and the 5’untranslated
region (UTRs) of the S. glossinidius FliC gene which
according to Majander et. al. [26] facilitates the extracel-
lular secretion of polypeptides via the type III pathway
in E. coli. The expression of the different Nb_An33 con-
structs was examined in both E. coli and S. glossinidius.
The pelB leader resulted in the extracellular release of
Nb_An33 from S. glossinidius and E. coli as shown by
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Western blot analysis (Figure 2). Here, the Nb_An33 is
present as a 13.8 kDa protein both in the periplasmic
fraction and cell-free culture supernatant of both bacter-
ial species. As this size is identical with the Nb_An33
that was expressed without any secretion signal, it con-
firms the correct cleavage of the pelB leader peptide
during periplasmatic transport. Moreover, the Nb_An33
devoid of the secretion signal accumulated exclusively in
the cytoplasm. The FliC-Nb_An33 fusion protein was
expressed in the cytoplasm of S. glossinidius and E. coli,
however in neither species was the fusion protein
exported to the periplasm nor extracellular medium.
Figure 2 shows that the fusion protein remained within
the cells as a 22.5 kDa protein, corresponding with the
molecular weight of the fusion construct. Finally, an
expression plasmid was constructed containing both
pelB and FliC secretion signals fused to Nb_An33 and
under the control of the FliC promotor, i.e. pFliC-
pelBNb33fliC. Here, Nb_An33 could be detected as a
13.8 kDa protein both in the periplasm and extracellular
medium of E. coli and S. glossinidius. Interestingly,
immunoblotting of cytoplasmic fractions shows that two
forms of the FliCpelB-Nb_An33 fusion protein could be
detected: Nb_An33 (13.8 kDa) and Nb_An33 coupled to
both pelB and FliC secretion signals (24,5 kDa). The
expression and localization of the Nb_An33 for the dif-
ferent expression constructs are summarized in Table 1.
Growth rates
In order to determine the overall effect of the Nb
expression and extracellular release on the bacterial fit-
ness, we examined the growth rates of S. glossinidius
Figure 1 Schematic presentation of the gene constructs used in this study. Lines represent untranslated DNA regions, filled bars the
coding region of Nb_An33 and open bars the coding regions of the respective secretion signals. All gene constructs contain a 6xhis tag (6H) at
the carboxy terminal end for purification purposes. Plac and PFliC indicate the lac promoter and the promoter region of the S. glossinidius fliC
gene respectively. 5’-UTR indicates the 5’ untranslated sequence of fliC including the fliC promotor. FliC1-70 refers to the size in amino acids of
the fragment of the S. glossinidius FliC protein containing the predicted signal sequence.
Figure 2 Qualitative analysis of intracellular (cytoplasmic and periplasmic) and extracellular Nb_An33 fusion proteins expressed from
E. coli (left panel) and S. glossinidius (right panel) harboring the different expression plasmids. E. coli and S. glossinidius samples were not
normalized for cell density as these two host cells reach different cell densities at early stationary phase. The localization of the expressed Nb-
An33 fusions were analyzed by immunoblotting of cytoplasmic (C) and periplasmic (P) fractions and medium supernatant (S) using an anti-His
antibody (1:1000 Serotec) for detection. Presented data are representative for at least three independent experiments. Molecular size markers in
kDa are indicated on the gels.
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strains harboring the various expression constructs and
compared them to the WT strain (Figure 3). Under
standard microaerophilic conditions S. glossinidius
divides very slowly, however they can be grown under
oxidative stress once cultures have reached a cell density
sufficient to ensure activation of the oxidative-stress
response regulated via a quorum-sensing mechanism
(OD600: 0.03; [27]). Therefore, cultures were grown
without shaking for the first 48 h and then transferred
to a shaking incubator. The growth curves of the S. glos-
sinidius strains periplasmatically expressing Nb_An33 (S.
glossinidius:ppelBNb33lac and S. glossinidius:pFliC-
pelBNb33fliC) were indistinguishable from the WT
strain. However, S. glossinidius strains expressing
Nb_An33 cytoplasmatically (S. glossinidius:pNb33lac and
S. glossinidius:pFliCNb33fliC) showed a lower maximum
density as compared to the WT strain (Figure 3). These
results are consistent with the calculated cell population
doubling time of the different strains during the
exponential growing phase of the culture. The doubling
times (in hours) for the Nb_An33 exporting strains are
identical with that of the WT strain whereas the Nb
non-exporting Sodalis strains demonstrated an elevated
doubling time: WT, 7.75 h ± 0.07; pNb33lac, 8.74 h ±
0.1; ppelBNb33lac, 7.87 h ± 0.04; pFliCNb33fliC, 8.92 h
± 0.15; pFliCpelBNb33fliC, 7.80 h ± 0.14. These data
indicate that intracellular expression of Nb_An33 has an
inhibitory effect on growth compared to the WT strain,
while secreting strains are not affected in their growth.
Quantitation of extracellular Nb_An33
Nb_An33 expression and release was quantified by mea-
suring the concentration of active Nb_An33 in the whole
cell fraction and supernatant using enzyme-linked immu-
nosorbent assay (ELISA). Extracellular and intracellular
concentrations of Nb_An33 produced by S. glossinidius
harboring the pelBNb33lac and FliCpelBNb33fliC plas-
mids were analyzed at different time points during bacter-
ial growth over a 8-day period and results are shown in
Figure 4. During logarithmic growth (day 3) of the pelBN-
b33lac harboring strain, a release efficiency of 20% was
estimated, calculated as the percentage of the Nb present
in the culture medium on the total amount of expressed
Nb. The release efficiency increased to 25% during station-
ary phase, i.e. day 4. During this stage of the growth curve
(day 1- day 4) no significant cell death occurred as mea-
sured by the Live/Dead BacLight bacterial viability test
(data not shown). After the cells reached saturation, a
drastic increase of active extracellular Nb_An33 was mea-
sured from 60% of total protein at day 5 to 80% at day 8.
Here, active Nb_An33 accumulated in the culture medium
of S. glossinidius expressing pelBNb33 at concentrations of
160 ng/ml. The release efficiency of S. glossinidius harbor-
ing the FliCpelBNb33fliC plasmid showed a similar pat-
tern as the pelBNb33lac harboring strain with an
efficiency of 35% and 81% at day 4 and 8 respectively.
However, the amount of active intra- and extracellular
Nb_An33 produced by S. glossinidius expressing FliC-
pelBNb33 was lower compared to the pelBNb33 expres-
sing strain. Given that these concentrations were
determined by a VSG-binding ELISA these results indicate
Table 1 Summary of the gene constructs expressed in S. glossinidius, cellular localization of the resulting polypeptides
and characteristics of the recombinant S. glossinidius strains i.e., culture doubling time (mean ± SD) and protein yields
at day 8 (mean ± SD).
Expressed gene construct Cellular localization Culture doubling time Protein yield (day 8) (ng/ml of culture)
I E
Nb_An33 C 8.74 h ± 0.1 BDL BDL
pelBNb_An33 C, P, S 7.87 h ± 0.04 26.54 ± 3.6 111.05 ± 114
FliCNB_An33 C 8.92 h ± 0.15 BDL BDL
FliCpelBNb_An33 C, P, S 7.80 h ± 0.14 10.61 ± 0.9 46.97 ± 6.3
Cellular localization; C, cytoplasmic; P, periplasmic and S, supernatant. Protein yield; I, intracellular; E, extracellular. BDL, Below detection limit.
Figure 3 Growth curve analysis of S. glossinidius expressing
and/or secreting recombinant Nb_An33. The error bars show the
± SD of two biological replicates. Samples were taken every 24 h
except during exponential growth (day 3 and 4), 2 samples/24 h
were taken (a and b).
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that the Nb_An33 expressed by recombinant S. glossini-
dius is functional in terms of antigen-binding.
Nb_An33 released by Sodalis glossinidius targets live
trypanosomes
The functionality of the extracellularly released
Nb_An33 was further evaluated by analyzing its binding
ability to living trypanosomes via flow cytometry and
microscopy. Sodalis cells periplasmatically expressing
Nb_An33 was grown in a 1.5 L liquid culture to an
OD600 0.5. Nb_An33 was purified from the periplasm by
immobilized metal affinity chromatography and gel fil-
tration (Figure 5). The eluted fractions were pooled and
concentrated on Vivaspin concentrators. Comparison of
Figure 4 ELISA based Nb_An33 quantitation using a 6 × His tag specific detection antibody in order to determine the intra- and
extracellular nanobody concentration produced by S. glossinidius harboring pelBNb33lac and FliCpelBNb33fliC plasmids at selected
time points. Samples were taken every 24 h except during exponential growth (day 3 and 4), 2 samples/24 h were taken (a and b). Values are
presented as ng recombinant protein per ml culture medium. The error bars show the ± SD of two biological replicates. Presented data are
representative for two independent experiments.
Figure 5 Size-exclusion chromatography profile (solid line) of the Ni-NTA eluted periplasmic extract from S. glossinidius expressing
FlicpelBNb33 loaded onto a Superdex-75 (10/30) column using PBS as running buffer. Affinity purified S. glossinidius Nb_An33 eluted at
the positions indicated by the arrow. The dotted line represents the elution pattern of Nb_An33 purified from E. coli. Eluted fractions containing
S. glossinidius Nb_An33 were pooled and purity was evaluated by SDS-PAGE gel electrophoresis and anti-His Western blot (inset).
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the size exclusion chromatograms of Nb_An33 pro-
duced by Sodalis versus E. coli reveals identical reten-
tion times. The purity of the concentrated eluded
fractions was confirmed via immuno- and Coomassie
staining (Figure 5, inset). Flow cytometry analysis
showed that purified trypanosomes expressing AnTat1.1
VSG were stained upon the addition of Alexa488-
labelled Nb_An33 (Figure 6A, green histogram). In the
same experimental set-up, parasites were incubated with
a control Alexa488-labelled Nb with no VSG specificity
and the profile is indistinguishable from an unstained
sample of parasites (Figure 6A, dashed and red histo-
gram). Analysis of the samples by immunofluorescence
microscopy showed a staining of the living parasites
over their entire surface when incubated with Alexa488-
labeled Nb_An33 at 4°C. However, during the microsco-
pical analysis at room temperature (RT) the fluorescent
labeled Nb accumulated mainly in the trypanosome fla-
gellar pocket (FP) (Figure 6B). Together, these results
provide definite evidence that Nb_An33 released by S.
glossinidius is fully functional and able to target its spe-
cific epitope that is present in the dense VSG coat of
living parasites.
Discussion
Genetically modified bacterial symbionts of arthropod
disease vectors are potential tools for the delivery of
proteins that interfere with pathogen development in
the vector and may serve as a powerful complementary
approach to control disease transmission [2]. Further-
more, the use of bacterial symbionts expressing foreign
proteins in disease-carrying arthropods has also an
intriguing potential for studying insect-pathogen inter-
actions. The advent of Nanobody® technology has
offered new prospects for the development of new
effector molecules applicable for the paratransgenesis
approach. These single-domain antigen-binding frag-
ments represent exquisite targeting tools because of
their small size (13-15 kDa) and stability properties
[17,22]. Despite the interest for a paratransgenesis
Figure 6 Recognition of living trypanosomes expressing AnTat1.1 by ALEXA488-labelled Nb_An33 purified from S. glossinidius. A) Flow
cytometry profile Red histogram: profile of parasites in the absence of Nbs. A non VSG specific Alexa488-labelled control nanobody did not
significantly bind to the trypanosome surface (Blue dashed histogram). Green histogram: profile of parasites bound by Alexa 488-labelled
Nb_An33 secreted by Sodalis glossinidius. B) Immuno-fluorescence microscopy. When maintained at room temperature surface bound Alexa488-
labelled Nb_An33 gradually accumulated in the parasite flagellar pocket (FP).
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approach in tsetse flies to control transmission of Afri-
can trypanosomiasis, little progress has been made on
the identification and expression of trypanosome-inter-
fering proteins in the tsetse fly bacterial endosymbiont
Sodalis glossinidius. To date, S. glossinidius strains
have only been used as hosts for the production of
GFP [1]. In this study we explored the possibility of
expressing a trypanosome-interfering Nanobody® in
Sodalis glossinidius. We have developed a suitable
expression vector that allows for the expression in S.
glossinidius of an anti-trypanosome Nanobody®,
Nb_An33 that targets a high-mannose carbohydrate
epitope present on the Variant-specific Surface Glyco-
protein of Trypanosoma brucei [24].
Importantly, to control parasites in the tsetse fly, it is
imperative for the effector molecules to reach their tar-
get. In an effort to address the need for an efficient
secretion system we evaluated two distinct bacterial
secretion pathways in their capacity to deliver Nbs to
the extracellular environment. Nb_An33 fused to the S.
glossinidius FliC secretion signal was expressed by both
S. glossinidius and E. coli. However, in neither species
could the fusion protein be detected in the culture med-
ium nor the periplasm. The underlying reasons for this
secretion failure remains unclear. One possibility
includes the presence of a functional Sodalis glossinidius
flagellar cap protein FliD, responsible for the polymeri-
zation of the FliC monomers into a filament, which
would hinder the release of the FliC-fusion protein into
the extracellular medium [26].
Nb_An33 was successfully exported to the S. glossini-
dius and E. coli periplasm using the pelB signal peptide.
Furthermore, in both species the recombinant protein
accumulated in the culture medium with an extracellu-
lar export efficiency in Sodalis of 20-25% during expo-
nential and stationary growth phase where cell lysis is
negligible. The extracellular release of small proteins
and antibody fragments that were secreted into the peri-
plasm via the pelB signal peptide has already been
described [7,28]. The occurrence of this phenomenon
appears to be highly dependent on the characteristics of
the protein and is not yet fully understood. The secre-
tion of some recombinant proteins to the periplasm is
suggested to cause a destabilization of the outer mem-
brane, which becomes leaky and results in the non-spe-
cific release of periplasmic proteins to the extracellular
environment [29,30]. The pelB signal peptide is known
to direct protein translocation to the periplasm via the
Sec-dependent type II secretion pathway [31]. The feasi-
bility of this pathway to export heterologous proteins to
the periplasm of S. glossinidius complements the twin-
arginine translocation (Tat) pathway, also involved with
periplasmic transport, which was previously demon-
strated to be functional in Sodalis glossinidius [32].
Additionally, the ELISA results indicated that during
the stationary and cell lysis phase of the growth curve,
S. glossinidius cells harboring the ppelBNb33lac plasmid
released functional Nb_An33 in the culture medium
where it accumulated at concentrations as high as 160
ng/ml. This clearly indicates that the release of Nbs
from lysing Sodalis cells to the extracellular environ-
ment could also be an important way for the expressed
Nb to reach its trypanosome target in the lumen of the
tsetse fly. For both S. glossinidius strains harboring
pNb33lac and pFliCNb33fliC, the amount active
Nb_An33 expression was below the detection limit in
ELISA, probably due to the fact that biological activity is
dependent on correct protein folding involving the for-
mation of disulfide bonds which is unlikely to occur in
the reducing environment of the cytoplasm. The ELISA
results also demonstrated that the secreted Nb_An33
was perfectly functional in terms of antigen binding to
purified soluble AnTat 1.1 VSG in vitro.
Another important consideration when expressing
potential effector proteins into the midguts of blood
feeding arthropods is the susceptibility of the effectors
to proteolytic degradation. Spiking of midgut extracts
from tsetse flies with purified Nb_An33 in an ELISA
assay demonstrated that Nb_An33 retains its antigen
binding properties (unpublished results), providing preli-
minary evidence that Nb_An33 remains functional
within the midgut environment of the fly. Furthermore,
Nbs can easily be mutagenized and selected for
increased proteolytic stability [33].
Finally, the capacity of the secreted Nb_An33 to
recognize its epitope on living trypanosomes was con-
firmed by flow cytometry and fluorescence microscopy
using alkaline binding conditions that are relevant for
the tsetse fly midgut physiology.
Growth curve analysis and cell population doubling
time of the S. glossinidius strains harboring the different
expression constructs showed that there was a strong
correlation between the ability of the S. glossinidius
strains to export the Nb_An33 fusion protein and
growth performance. Strains expressing Nb_An33 intra-
cellularly showed a significant reduction in growth rate
compared to the WT strains, while secreting strains
were not affected in their growth. These results suggest
that accumulation of Nb_An33 in the cytoplasm imparts
a detrimental effect on growth performance and that
efficiently secreting Nb_An33 to the periplasm rescues
this effect, allowing the strain to grow with kinetics
similar to the WT strain.
Conclusions
This study provides the first demonstration of the func-
tional expression and extracellular delivery of trypano-
some-interfering proteins in S. glossinidius. Moreover,
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we demonstrated that S. glossinidius expressing pelBN-
b_An33 exhibited no significant reduction in terms of
fitness, determined by in vitro growth kinetics, com-
pared to the wild-type strain. This ability of the recom-
binant S. glossinidius strain to effectively compete with
native strains is of great importance to the overall suc-
cess of the paratransgenesis strategy. Given the ability of
S. glossinidius to express high levels of active Nb_An33
and the capacity to release this anti-trypanosome Nb
without hampering the bacterium viability, the founda-
tion has been laid for further exploration of the inhibi-
tory effect on trypanosome development in the tsetse
fly. For this, highly potent trypanolytic Nbs have been
developed very recently that lyse trypanosomes both in
vitro and in vivo by interfering with the parasite endocy-
tic pathway [34].
The current study also reinforces the notion for the
potential of S. glossinidius to be developed into a para-
transgenic platform organism. At a broad level, the con-
cept of using Nbs as effector molecules to be delivered
by bacterial endosymbionts is not limited to the tsetse
fly-trypanosome model but could also be applied in a
paratransgenic approach to encompass other vector-
borne diseases.
Methods
Insects, bacterial strains and culture conditions
Sodalis glossinidius strains used in this study were iso-
lated from the hemolymph of surface-sterilized Glossina
morsitans morsitans from the colony maintained at the
Institute of Tropical Medicine (Antwerp, Belgium). Cul-
tures were maintained in vitro at 26°C in liquid Mitsu-
hashi-Maramorosch (MM) insect medium (PromoCell)
supplemented with 10% (v/v) heat-inactivated fetal
bovine serum (FBS). For cloning, S. glossinidius strains
were cultivated on MM agar plates composed of MM
medium (without FBS) solidified by autoclaving after the
addition of 1% of bacto-agar. Blood agar plates were
supplemented with 10% packed horse blood cells (IMP)
and yeastolate (5 mg/ml) (Gibco). All solid cultures
were cultivated in micro-aerophilic conditions generated
using the Campygen pack system (Oxoid) which pro-
vided 5% O2, 10% CO2, balanced with N2 at 26°C.
Where appropriate, antibiotics were added to the media
at the following concentrations: 100 μg/ml of ampicillin
and 50 μg/ml of kanamycin.
Plasmids constructs
Plasmids used in this study and the structure of the
fused genes are shown in Figure 1. Nb_An33, coupled
to the pelB leader sequence and followed by a 6xHis
tag was amplified as a XbaI-EcoRI fragment by PCR
from the pHen6C plasmid containing the pelBNb33
gene using the following primer set: pelBNb33_FW, 5’-
TTTTTCTAGAATGAAATACCTATTGCCTACGG-3’
and Nb33_Rev, 5’- TTTTGAATTCTTAGTGATGGT-
GATGGTGGTGTGAGGAGACGGTGACCTG-3’
(XbaI-EcoRI restriction sites are underlined). The
resulting 438 bp PCR product was cloned into pCM66
[35] to create ppelBNb33lac. Nb33_FW, 5’-ATATTC-
TAGATGATGTGCAGCTGGTGGAGTC-3’ was used
to create pNb33lac without any secretion signal. To
create pFliCNb33fliC and pFliCpelBNb33fliC, a 510 bp
fragment including the FliC promoter region (PfliC)
and a 210 bp fragment FliC, encoding 70 N-terminal
amino acids of the S. glossinidius FliC gene, was
inserted in-frame between the SphI-XbaI restriction
sites of pNb33lac and ppelBNb33 respectively, with
the following primer set: FliC_FW, 5’- GCATGC-
CATGTCCCAGGTCATT-3’ and FliC_Rev, 5’-ATATC-
TAGAGTCATTGGCGCATG-3’(SphI-XbaI restriction
sites are underlined). All plasmids were sequenced to
confirm the desired DNA sequence and the correct
reading frame.
Genetic transformation of Sodalis glossinidius
Plasmid constructs were transformed in wildtype (WT)
S. glossinidius cells using a heat-shock method [2].
Transformed cells were allowed to recover overnight at
26°C prior to plating onto MM-blood agar, supplemen-
ted with kanamycin and a single recombinant S. glossini-
dius colony was inoculated into liquid culture.
Western Blot Analysis
Cultures were grown to the beginning of stationary
phase (S. glossinidius OD600 0.5-0.6; E. coli OD600 1,5-2).
Cells were pelleted from bacterial cultures by centrifuga-
tion (15 min, 10000 × g) and the supernatant was clari-
fied from residual bacterial cells by a second
centrifugation step. Proteins in the growth medium
were precipitated with 10% trichloroacetic acid (TCA)
for 1 h on ice. From the pelleted cells, periplasmic pro-
teins were extracted by osmotic shock [36]. For SDS-
PAGE, samples were heat denatured at 95°C in the pre-
sence of SDS-PAGE loading buffer containing b-mer-
captoethanol and analyzed on a 12% (w/v)
polyacrylamide gel. Proteins were transferred onto a
nitrocellulose membrane (Whattman). After overnight
blocking with 1% (w/v) bovine serum albumin, the
membrane was incubated sequentially with a mouse
anti-6xHis-tag IgG1 antibody (1:1000) (Serotec) and a
rabbit anti-mouse-IgG antibody (1:1000) (Serotec) con-
jugated to horseradish peroxidase. In between these suc-
cessive 2 h incubations, the membrane was washed with
PBS-0.1% Tween 20. Thirty minutes after adding the
substrate (TMB 1-Component Membrane Peroxidase
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Substrate, KPL) the reaction was stopped by washing the
membrane with water.
Growth curve measurements
Logarithmically growing cultures were used to inoculate
25 ml of MM-medium to an optical density at 600 nm
(OD600) of 0.005. Cultures of the different S. glossini-
dius strains were allowed to grow without shaking for
48 h and samples were taken every 24 h. Then cultures
were transferred to a shaking incubator and grown in
alternating cycles (12 h) of static and shaking conditions.
During the exponential growth rate 2 samples/day were
taken. Doubling times during exponential growing phase
were calculated using the following equation: doubling
time (in hours) = h*ln(2)/ln(c2/c1) where c1 is the initial
concentration and c2 is the concentration when cultures
reached maximum densities.
Analysis of fusion protein concentrations using ELISA
The amount of active Nb_An33 present in cytoplasmic
extracts and growth medium was quantified using an
optimized Nanobody Solid-phase Binding enzyme-linked
immunosorbent assay (ELISA) [37]. Samples were taken
at the same time points indicated for the growth curve
measurements. At each time point, 1 ml of culture
media was centrifuged two times (8000 × g) to obtain
the extracellular and whole cell fractions. The whole cell
extracts were prepared by resuspending the cell pellets
in 0.2 ml PBS supplemented with protease inhibitor
(Roche) followed by sonication at an amplitude of 10
μm for 5 s (3 cycles on ice).
Maxisorb 96-well plates (Nunc) were coated over-
night (4°C) with 200 ng purified soluble AnTat 1.1
VSG (target of Nb_An33) per well in 0.1 M NaHCO3,
pH 8.2. Residual protein binding sites were blocked for
two hours at room temperature with 0.5% bovine
serum albumin (BSA) in PBS. In order to quantify
Nb_An33 present in cytoplasmic extracts and growth
medium, a standard serial dilution series (1:2) starting
from 2500 to 5 ng/ml of purified Nb_An33 was pre-
pared in PBS and MM-medium respectively. MM med-
ium and PBS alone were included as blanks. Standards,
cytoplasmic and extracellular fractions were added for
1 h at room temperature. Detection of antigen-bound
Nanobodies was performed with a mouse anti-6xHis
IgG antibody (Serotec) directly conjugated to horserad-
ish peroxidase. Thirty minutes after adding peroxidase
substrate, the reaction was stopped with 0.33 M
H2SO4 and the optical density was measured at 450
nm (690 nm was used as reference filter). Protein con-
centrations were calculated from a standard curve
fitted to a four parameter logistic equation using the
Ascent software (Labsystems).
Parasites and VSG purification
Purification of Trypanosoma b. brucei AnTat1.1 soluble
VSG was prepared as described earlier [23]. Trypano-
soma b. brucei AnTat1.1 bloodstream parasites were
grown in mice and purified from their heparinized
blood by using diethylaminoethyl cellulose (DEAE)
anion exchange chromatography on mAECT columns
[38]. Mouse care and experimental procedures were per-
formed under approval from the Animal Ethical Com-
mittee of the Vrije Universiteit Brussel, (VUB), Belgium
(ethical clearance N° 09-220-08).
Purification and ALEXA-488 labelling of Nb_An33
produced in Sodalis glossinidius
Large-scale production of Sodalis Nb_An33 was per-
formed in 500 ml shake flasks by growing the bacteria
in an orbital shaker at 200 rpm to an OD600 nm of
approximately 0.5. After cells were pelleted, periplasmic
proteins were extracted by osmotic shock [36] and med-
ium was concentrated and extensively dialyzed (6-8 kDa
MWCO Spectra/Por dialysis membrane, Spectrum
laboratories) against PBS. Proteins were purified from
the periplasmic fraction and medium using affinity chro-
matography on a Ni-NTA Superflow column (Qiagen).
The eluted fractions were concentrated on Hydrosart
Vivaspin concentrators with a molecular mass cutoff of
5 kDa (Vivascience). Further purification was performed
by size-exclusion chromatography (AKTA explorer, GE
Healthcare) using a Superdex75 (HR10/30) column
equilibrated with PBS and the purity of the proteins was
evaluated by Coomassie-stained 12% SDS-polyacryla-
mide gel and their identity confirmed by 6 × His tag
specific immunodection in Western blot. ALEXA Fluor
488 labelling of the nanobody was accomplished using
the Alexa Fluor® 488 Monoclonal Antibody Labeling Kit
(Molecular Probes) according to the manufacturer’s
instructions. To separate the nanobody from free label,
a second Superdex 75 (HR10/30) gel filtration chroma-
tography was performed.
Flow cytometry analysis and Immunofluorescent
Microscopy
The binding capabilities of the labeled and purified
Nb_An33 from S. glossinidius was evaluated on live,
bloodstream form AnTat1.1 trypanosomes through flow
cytometry. Aliquots of purified parasites (2 × 105 in 20
μl HMI-9 medium + 15% FCS, pH 8, [39]) were cooled
on ice prior to adding ALEXA-labeled Nb_An33. After
30 min of incubation parasites were washed (8 min, 850
× g) with HMI9 medium to remove free label and ana-
lyzed in by flow cytometry on a FACS Canto II and his-
tograms were prepared using the FlowJo software
(Becton Dickinson, San Jose, CA). Immunofluorescence
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microscopy was performed on the same samples using a
Nikon ECLIPSE E600 epifluorescence microscope
equipped with a Plan Apo 60 × oil-immersion objective
lens.
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